Novartis Stock
Novartis AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Switzerland
- CEO
- Vasant Narasimhan
- Employees
- 75,267
- Market cap
- CHF237 B
- IPO
- 08/03/1996
Novartis AG is a healthcare company operating as a drug manufacturer with its headquarters in Basel, Switzerland. The company was listed on the SIX Swiss Exchange on March 8, 1996, and currently employs 75,267 employees. Its business model involves researching, developing, manufacturing, distributing, marketing, and…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Novartis stock: price history
1D
-1.0%
1W
+4.7%
1M
+9.1%
6M
+4.9%
YTD
+13.8%
1Y
+19.5%
2Y
+23.7%
5Y
+62.1%
10Y
+87.1%
Next earnings date
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~8% stronger price swings than usual
Ask the agents about Novartis
Analyst assessment of Novartis
1
STRONG BUY
4
BUY
14
HOLD
1
SELL
0
STRONG SELL
20
TOTAL · Hold
As of: 24/09/2023
Novartis stock metrics
P/E
22.95
P/B
6.92
EV/EBITDA
14.88
RETURN ON EQUITY
7.7%
NET MARGIN
22.7%
DEBT/EQUITY
1.18
DIVIDEND YIELD
3.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.7%
FLOAT SHARES
1,856,409,177
AVG. DAILY VOLUME (30D)
3,556,451
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Novartis stock
What does Novartis do?
Novartis AG is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Switzerland.
The CEO is Vasant Narasimhan, the company employs around 75,267 people.
The IPO was on 08/03/1996; the stock trades on SIX under the ticker NOVN.SW.
What do analysts say about Novartis stock?
20 analysts rate the stock, the consensus is Hold (as of 24/09/2023).
This is an external assessment, not a statement by Market Jury.
When does Novartis report next?
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 8% stronger than usual.
Does Novartis pay a dividend?
Yes. The last dividend was CHF 3.70 per share, ex-date 10/03/2026, paid on 12/03/2026.
The dividend yield is 3.0% (as of 30/06/2026).
Which stocks are comparable to Novartis?
Comparable stocks include Roche Holding, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences and Pfizer.
How can I get Novartis stock analyzed?
Clicking "Analyze stock" lets five strategies assess Novartis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.